MedTrace Logo

Rapid Diagnostic Test for Septic Arthritis

NCT04460144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2023-01-04

No results posted yet for this study

Summary

Diagnostic Validation Study of a Test Based on the Analysis of the Proteome by Mass Spectrometry for the Diagnosis of Septic Arthritis in Children Under 16 Years of Age

Conditions

  • Juvenile Idiopathic Arthritis
  • Arthritis, Septic
  • Arthritis, Unspecified

Interventions

DIAGNOSTIC_TEST

Mass spectrometry

Proteomic analysis

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Ulrich MEINZER, MD-PhD · APHP

  • Stephane BONACORSI, MD-PhD · APHP

Eligibility

Min Age
3 Months
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2022-10-21
Completion
2022-12-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04460144 on ClinicalTrials.gov